# Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)

> **NCT04990063** · PHASE1 · UNKNOWN · sponsor: **suhaichuan** · enrollment: 20 (estimated)

## Conditions studied

- Advanced Non-small Cell Lung Cancer
- Chemotherapy

## Interventions

- **DRUG:** Chemotherapy
- **BIOLOGICAL:** Adoptive TKC transfer therapy

## Key facts

- **NCT ID:** NCT04990063
- **Lead sponsor:** suhaichuan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-08-08
- **Primary completion:** 2022-08-08
- **Final completion:** 2023-11-30
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2021-08-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04990063

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04990063, "Adoptive TKC Transfer Combined With Chemotherapy for Advanced Non-small Cell Lung Cancer (NSCLC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04990063. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*